This may be your best chance. The last PR indicates the results that are coming should be good. My guess is those good results accompany an r/s to get the company back on track. At that point you guys have missed your best chance to cover which is now because the massive short position will squeeze hard.
This is very encouraging but it is pre-clinical so who knows if it will advance to human trials but could be an indicator of what may come down the line. The Tactimel trial could yield some really amazing results. That is where IMP321 will be combined with Keytruda.
The current study has shown that treatment with the combined adjuvant of poly(I:C) plus LAG-3-Ig profoundly enhances antitumor responses induced by tumor peptide vaccine and leads to complete regression of pre-established tumor in association with long-term immunological memory. Furthermore, mechanistic analyses revealed the activation of Th1-type responses and prevention of the exhausted phenotype in tumor-specific T cells by this treatment. To the best of our knowledge, our study is the first to report a great advantage in combining adjuvants poly(I:C) and LAG-3-Ig for therapeutic cancer vaccine. (Lag-3-lg is Prima's IMP321.)
I have been thinking the same thing as well. Something is coming. Novartis and GSK would not be already partnered on the other IMP trials for nothing. If you read up on Lag3 and its potential to be a better marker than PD-1 then it makes you excited about this one's potential. I think there is a lot of misunderstanding around this stock because of its dual listing on the ASX. I see shorts that don't even understand the exchange rates/ADR.
Search that exact phrase on YT for a long TV interview from Nov. 25th with Prima's CEO if you want to learn about the company. He discussed everything and talks about the partnerships already in place.
1. Chair of the Board - Lucy Turnbull is the new PM of Australia's wife.
2. Chief Science/Medical Officer - Frédéric Triebel - Discovered Lag3 in 1990.
Just look at the Lag3 on Wikipedia. It is basically about Prima.
Sentiment: Strong Buy
Look up the old Aegis upgrades. It was this same guy, Yi Chen, and the price just keeps plummeting. He put a $16 dollar price target on it, reiterated it a second time and it has gone straight down. He keeps citing the science but ignores the -4,982.14% net profit margin. Now he is with a different company and puts a $4 dollar target on it. Something stinks. There is no way this company can get things going from a revenue standpoint to offset the horrible profit margins before they start diluting out of the 50 million dollar shelf they filed back in May. The economies of scale they need would be massive and there are 30 other companies working on liquid biopsy. Some with far greater resources like J&J and Thermo-Fischer. Look at TBIO as an example, they had 7 million in Q2 sales/revenue and their stock is $1.28. BIOC had 76 thousand in Q2 revenue. and the cost of that revenue was 976 thousand. Pitiful. I was a believer and a pumper here but have learned some valuable lessons from this junk stock. It is absolute junk.
The upgrade was the same analyst that has given all the false upgrades. He used to work at Aegis where he gave the previous upgrades. He is either shorting these upgrades or he is just terrible and Aegis fired him for his terrible upgrades. HC Wainwright also upgraded GEVO today too so you know that something fishy is going on.
Considering there has been no announcement that Anthem/Cigna is reimbursing BIOC tests then there is no way anyone can believe this. That news would be a big deal and they would have issued a press release.
Typical gap up and fade. Some idiot ran it up to 14.50 in pre-market on 6300 shares so it was inevitable that the algos would slam it back down to close the gap. Just short term overbought conditions but still buying pressure. It is still slowly heading upwards and still looks bullish to me.
It could have been a number of things such as some sort of stock based compensation plan where restricted get converted to common and it shows up on these websites as a purchase when they didn't really spend their own money. Not sure without seeing the actual filing. I am not sure why he would spend his own money knowing they were about to post the awful financials that they posted last night that tanked the stock. Wish I would have seen them and I would have shorted this today.
Ever heard of quotations? Who is dumb here? If you believe them that is fine but I wouldn't trust them. I don't care either way but oil just keeps plummeting and so does this stock. I currently have no position here but I have no idea why anyone would be holding oil long until there are clear signs of a reversal.
If you are really from the company and you are posting this stuff on a public message board then that is a huge red flag.